CuraGen Corp. subsidiary 454 Life Sciences, a Branford, Conn.-based developer of genome-scale sequencing technologies, today announced that it has obtained an exclusive license for sole use of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback